Integration of PKPD relationships into benefit-risk analysis
Author:
Affiliation:
1. Division of Pharmacology; Leiden Academic Centre for Drug Research; the Netherlands
2. Clinical Pharmacology & Therapeutics; University College London; London
3. Clinical Pharmacology Modelling & Simulation; GlaxoSmithKline; Stockley Park UK
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12674/fullpdf
Reference129 articles.
1. A review of quantitative risk-benefit methodologies for assessing drug safety and efficacy-report of the ISPOR risk-benefit management working group;Guo;Value Health,2010
2. Risk assessment and cost-effectiveness/utility analysis;Busch;Biol J Int Assoc Biol Stand,2009
3. Balancing early market access to new drugs with the need for benefit/risk data: a mounting dilemma;Eichler;Nat Rev Drug Discov,2008
4. Benefit-risk analysis : a brief review and proposed quantitative approaches;Holden;Drug Saf,2003
5. Interpretation of drug risk and benefit: individual and population perspectives;Bjornson;Ann Pharmacother,2004
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Appropriate design and reporting of superiority, equivalence and non-inferiority clinical trials incorporating a benefit–risk assessment: the BRAINS study including expert workshop;Health Technology Assessment;2023-10
2. Dose rationale for gabapentin and tramadol in pediatric patients with chronic pain;Pharmacology Research & Perspectives;2023-10
3. Avaliação do risco potencial: da teoria à prática em Vigilância Sanitária;Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia;2021-08-31
4. Model-Informed Repurposing of Medicines for SARS-CoV-2: Extrapolation of Antiviral Activity and Dose Rationale for Paediatric Patients;Pharmaceutics;2021-08-19
5. Concept and utility of population pharmacokinetic and pharmacokinetic/pharmacodynamic models in drug development and clinical practice;Arhiv za farmaciju;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3